Circadian Rhythm Disorders and Parkinson’s Disease News A Closer Look Archives | American Parkinson Disease Association Aug. 4, 2026
Apokyn (apomorphine hydrochloride) for Parkinson’s disease News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 4, 2026
Turmeric compound may protect motor function in Parkinson’s mouse model News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 4, 2026
New MJFF grant to fund lab studies of one-time Parkinson’s gene therapy News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 4, 2026
Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait Trial N/A Completed Aug. 3, 2026
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease Trial Phase 3 Recruiting Aug. 3, 2026
A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease Trial N/A Recruiting Aug. 3, 2026
Investigation of Exercise Capacity, Muscle Oxygenation and Physical Activity Level in Parkinson's Patients Trial N/A Completed Aug. 3, 2026
Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS Trial N/A Recruiting Aug. 3, 2026
FDA backs faster development path for Parkinson’s cell therapy News Parkinson's News Today – The Web's Daily Resource for Parkinson's News Aug. 3, 2026
Beyond motor fluctuations: Understanding the clinical correlates of OFF burden in Parkinson's disease News Sage Journals: Journal of Parkinson’s Disease: Table of Contents Aug. 3, 2026
Automatic sleep staging and atonia detection in RBD using single-channel chin EMG News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents Aug. 2, 2026
Phase â…˘ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease Trial Phase 3 Not yet recruiting Aug. 2, 2026
Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease Trial N/A Completed Aug. 2, 2026